Area of research
Pharmacology · Biological Psychiatry
Research interest
Research interests include Treatment of Major Depression, Tryptophan and brain disorders, Obsessive-Compulsive Spectrum Disorders, and Cancer Cells and Metastasis.
Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): randomised double-blind active-controlled trial
Efficacy and Safety of Repeated Subcutaneous Ketamine Injections for Treatment Resistant Depression - The KADS Study: A Randomised, Double-Blind, Comparator-Controlled Trial
Deep Transcranial Magnetic Stimulation Combined With Brief Exposure for Posttraumatic Stress Disorder: A Prospective Multisite Randomized Trial
The Significance of the Default Mode Network (DMN) in Neurological and Neuropsychiatric Disorders: A Review.
PubMed 2016cited by 310position: last
Elevated prefrontal cortex GABA in patients with major depressive disorder after TMS treatment measured with proton magnetic resonance spectroscopy
Ketamine for rapid reduction of suicidal ideation: a randomized controlled trial
Effects of Low-Dose and Very Low-Dose Ketamine among Patients with Major Depression: a Systematic Review and Meta-Analysis
Individual differences in the peripheral immune system promote resilience versus susceptibility to social stress
Efficacy of Intravenous Ketamine for Treatment of Chronic Posttraumatic Stress Disorder
A Randomized Controlled Trial of Intranasal Ketamine in Major Depressive Disorder
Ketamine for Treatment-Resistant Unipolar Depression